Mary Christine Smith
Director/Board Member presso ENDO INTERNATIONAL PLC
Patrimonio netto: 13 $ in data 31/03/2024
Posizioni attive di Mary Christine Smith
Società | Posizione | Inizio | Fine |
---|---|---|---|
ENDO INTERNATIONAL PLC | Director/Board Member | 29/07/2020 | - |
Independent Dir/Board Member | 29/07/2020 | - | |
ACCENTURE PLC | Human Resources Officer | - | - |
Corporate Officer/Principal | 01/11/2020 | - |
Storia della carriera di Mary Christine Smith
Precedenti posizioni note di Mary Christine Smith
Società | Posizione | Inizio | Fine |
---|---|---|---|
APPLE INC. | Corporate Officer/Principal | 01/01/2017 | 01/01/2020 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2001 | 01/01/2017 |
Formazione di Mary Christine Smith
Rutgers State University of New Jersey | Graduate Degree |
Loyola University Maryland, Inc. | Undergraduate Degree |
New York University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Irlanda | 3 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Settori
Consumer Services | 4 |
Electronic Technology | 2 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
APPLE INC. | Electronic Technology |
ACCENTURE PLC | Technology Services |
Aziende private | 2 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Mary Christine Smith
- Esperienza